Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Common contraindications cited in the research-use community include: anyone with active or recent cancer (BPC-157 and TB-500 promote angiogenesis), people with Wilson's disease or other copper-metabolism disorders (GHK-Cu component), anyone pregnant or breastfeeding (no safety data), and athletes subject to WADA testing (BPC-157 and TB-500 are prohibited)
Deeper injection than SubQ
Al Mahmud J, Biswas PK, Nahar K, Fujita M, & Hasanuzzaman M (2019)
Understanding Peptides: BPC-157, GHK-Cu & Beyond A Clinical Guide to Peptide Therapy in Philadelphia In the evolving landscape of functional and regenerative medicine, peptide therapy has surfaced as a sophisticated tool for addressing systemic imbalances at a molecular level
There is no limit on the number of uses
We are grateful to WH and KW for technical assistance with data collection
